DiscGenics

Description

DiscGenics is a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Founders:

Flagg Flanagan

Company Size:

11-50 

TechBuzz Articles:

DiscGenics Raises $50 Million for Novel Back Pain Treatment, Mark Tullis, October 21st, 2020

Buzzworthy Mentions:

DiscGenics Announces Positive Interim Data on Clinical Trial of IDCT Therapy, March 4th, 2022

DiscGenics Completes Enrollment in Japanese Study, April 30th, 2021

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Our mission is to shine a spotlight on all great things happening in the Utah technology/startup community and be a fair, independent voice for the Utah Tech Scene.

              Google News

All contents © 2022 IsoTalent Inc. All rights reserved.


Terms of Use and Privacy Policy

Newsletter - Sign up to receive TechBuzz News weekly